Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) saw a large drop in short interest in August. As of August 31st, there was short interest totalling 100 shares, a drop of 93.3% from the August 15th total of 1,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Ortho Regenerative Technologies Price Performance
ORTIF stock remained flat at $0.20 during mid-day trading on Wednesday. The company has a market capitalization of $6.86 million, a P/E ratio of -1.78 and a beta of -1.16. The business has a fifty day simple moving average of $0.20 and a 200 day simple moving average of $0.19. Ortho Regenerative Technologies has a 12-month low of $0.13 and a 12-month high of $0.45.
Get Ortho Regenerative Technologies alerts:Ortho Regenerative Technologies (OTCMKTS:ORTIF – Get Rating) last issued its earnings results on Thursday, June 23rd. The company reported ($0.02) earnings per share for the quarter. Analysts anticipate that Ortho Regenerative Technologies will post -0.08 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Noble Financial started coverage on Ortho Regenerative Technologies in a research report on Monday, July 11th. They issued an "outperform" rating and a C$1.35 price target on the stock.Ortho Regenerative Technologies Company Profile
(Get Rating)
Ortho Regenerative Technologies Inc, an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration.
Read More
- Get a free copy of the StockNews.com research report on Ortho Regenerative Technologies (ORTIF)
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
- Can Health Drink Maker Celsius Outrun Its Monster Rival?
- It's Time To Embrace Another 25% Decline In The S&P 500
- Four Cheap Stocks With Interesting Insider Activity
- These 3 Reports Will Tell Us Much About the Current Economy
Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.